This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Europe
Life Science Fundraising & Investment
25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)
Tickets
Menu
Tickets
keyboard_arrow_right

Day Two - Western European Summer Time (WEST)

keyboard_arrow_leftSearch & Filter
search
Day Two - Western European Summer Time (WEST)
search
Showing 1 of 1 Streams
11:10 - 11:30
Future-proofing Your Launch: Data and Strategies for What’s Next

The healthcare industry has always evolved, but the scale and pace of change have accelerated in recent years—with major shifts across policy, technology and the broader healthcare landscape. What do these changes mean for biopharma companies and how they bring products to market? How do they affect revenue potential, clinical program design and other critical launch preparations?


Join this session to:

  • Hear the latest research and data on what drives launch success today
  • Gain practical insights on how to prepare for future market dynamics
  • Learn from an expert panel discussion exploring real-world examples and implications for launch strategy
  • Mark Rayward-Smith - Principal, ZS
11:30 - 12:10
Future-proofing Your Launch: Data and Strategies for What’s Next Panel Discussion
  • Mark Rayward-Smith - Principal, ZS
  • Sandra von Meier - Head of Business Development Life Science, Terra Quantum
  • Pawel Przewiezlikowski - CEO, Ryvu Theapeutics
  • Georg Pirmin Meyer - SVP & Head of International, Blueprint Medicines
12:10 - 12:50
Early Commercial Strategy: Building Value from Day One
  • Matthias Hess - SVP Head of Europe, SpringWorks Therapeutics
  • Rasmus Just - Global Head, Business Development, M&A, Licensing, Search & Evaluation, ALK
  • Elin Trampe - CEO, Dicot Pharma
  • Jonas Båtelson - CEO, Curacell
  • Khatereh Ahmadi - Venture Partner, XGEN Venture
Showing 1 of 1 Streams
14:00 - 14:50
Oncology’s Next Frontier: Future Opportunities in an Ever-Growing Market
  • Sonal Patel - VP, Oncology Scientific Innovation, Johnson & Johnson Innovation
  • Alan Rigby - CEO, Epitopea
  • Ana Slipicevic - CEO, One-Carbon Therapeutics
  • Carlos Buesa - CEO, Oryzon Genomics
  • David Solomon - CEO, Thalia Therapeutics
14:50 - 15:40
How Market Access Strategy Impacts Investment Potential
  • Francis Pang - SVP, Global Market Access & International Geographic Expansion, Orchard Therapeutics
  • Sukaina Virji - Director, Camarco
  • Sonia Hallen - Investment Manager, Gilde Healthcare
Day One - Pre-Day
NextDay Two Showcases
Filter
Streams
Clear
Formats
Choose Day